Welcome to our dedicated page for SCOTTS MIRACLE-GRO CO SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SCOTTS MIRACLE-GRO CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SCOTTS MIRACLE-GRO CO's regulatory disclosures and financial reporting.
FMR LLC reports beneficial ownership of 4,096,621.40 shares of THE SCOTTS MIRACLE-GRO CO common stock, representing 7.0% of the class. For this position, FMR LLC has sole voting power over 4,072,438.45 shares and sole dispositive power over 4,096,621.40 shares, with no shared voting or dispositive power.
Abigail P. Johnson is reported with sole dispositive power over 4,096,621.40 shares, but no voting power. One or more other persons may have rights to receive dividends or sale proceeds from these shares, but no single person holds more than five percent of the outstanding common stock through these interests.
Hagedorn Partnership, L.P., a director and 10% owner of Scotts Miracle-Gro, reported sales totaling 30,000 common shares on August 3, 2026, in two transactions of 28,793 and 1,207 shares at weighted-average prices of $67.4234 and $68.1615, within price ranges of $67.00–$67.99 and $68.00–$68.99. The Rule 10b5-1 checkbox was not marked, and the shares are held by the partnership, whose general partners disclaim beneficial ownership except to their pecuniary interest.
SCOTTS MIRACLE-GRO CO executive Mark J. Scheiwer, EVP, CFO & CAO, reported an other acquisition of 2.652 Common Shares on July 31, 2026 at $56.55 per share. After this transaction, he directly holds 15,386.607 Common Shares and indirectly holds 493.482 shares through a 401(k) plan.
Scotts Miracle-Gro director, President and CEO Nathan Eric Baxter reported an other acquisition of 88.417 common shares on 2026-07-31 at $56.55 per share. After this transaction he held 90,465.5948 common shares directly and reported an indirect proportionate interest in 36,993 shares held through Hagedorn Partnership, L.P. under Exchange Act Rule 16a-1(a)(1).
Christopher Hagedorn, EVP & Chief Strategy Officer of Scotts Miracle-Gro, reported an acquisition of 3.8370 common shares on 2026-07-31 at $56.55 per share. The event is coded as Form 4 code J, described as an 'Other acquisition or disposition' and classified as a restructuring transaction. After this change, he directly holds 57,551.8654 common shares. The filing indicates the transaction was not made under a Rule 10b5-1 trading plan.
SCOTTS MIRACLE-GRO CO director Stephen L Johnson sold 1,170.9600 Common Shares on July 30, 2026 at $68.3200 per share in a sale described as an open market or private transaction. After this trade, he directly held 30,179.0400 Common Shares.
The Scotts Miracle-Gro Company reported third-quarter 2026 net sales of $1.17 billion, up 1% year over year. GAAP diluted EPS from continuing operations was $1.75, down 34%, reflecting impairment, restructuring and other non-recurring items, while diluted EPS including discontinued operations was $1.90.
On a non-GAAP basis, adjusted diluted EPS from continuing operations rose 8% to $2.82, and adjusted EBITDA was $246.3 million. Year-to-date, adjusted net income from continuing operations increased 16% to $390.2 million, even as GAAP net income declined 24% to $225.8 million, influenced by losses tied to the Hawthorne business divestiture.
Management raised full-year 2026 guidance for non-GAAP adjusted diluted EPS from continuing operations to $4.30 to $4.45 and reaffirmed expectations for low single-digit U.S. Consumer net sales growth, an adjusted gross margin of at least 32%, mid single-digit adjusted EBITDA growth, and free cash flow of $275 million. The net leverage ratio improved to 3.78x.